Quick Summary
Insurance Regulatory and Development Authority Ref: IRDAI/HLT/REG/CIR/29/02/2021 08th February, 2021 To CEOs of all General and Standalone Health Insurance Companies Sub: Modified guidelines on product filing in health insurance business Reference is invited to the provisions of Chapter III of Consolidated Guidelines on Product filing in Health Insurance Business (RefNo: IRDAI/HLT/REG/CIR/ 194/07/2020 dated 22nd July, 2020(the guidelines) specifying the File and Use Procedure in
Daily Limit Reached
You have reached your daily limit of 2 Free Notice & Circular
Subscribe to CCI PRO for unlimited access
Why Upgrade to CCI PRO?
- No Ads
- WhatsApp Community
- Daily E-Newsletter
- Unlimited Notice & Circular Access
- Profile Visitors
- Link Social Profiles
- Featured Job Posts
- Pro Badge
- Expert GST Guidance
- Unlimited Forum Replies
- Download Content in PDF
1 Year PLAN
1999
(Excl. of GST ₹359)
BEST VALUE
2 Years PLAN
3499
(Excl. of GST ₹629)
View all CCI PRO benefits
Already a PRO member? Login here for an ad-free experience. 011-411-70713
FAQ :
The notification details modified guidelines for product filing in the health insurance business, specifically regarding the 'Use and File' procedure.
Personal accident insurance products, overseas travel insurance products, domestic travel insurance products, and benefit-based health insurance products are permitted under the 'Use and File' procedure.
Yes, for personal accident, domestic travel, and overseas travel products, the 'Use and File' procedure is only allowed if the coverage offered is contingent upon an accident and/or travel.
If an insurer is found non-compliant, the IRDAI may direct them to withdraw the product or withdraw the 'Use and File' facility for a specified period.
These norms are applicable to products filed from April 1st, 2021, onwards.
CAclubindia
Guest
Notification No : Ref: IRDAI/HLT/REG/CIR/29/02/2021Published in Miscellaneous
Source : https://www.irdai.gov.in/ADMINCMS/cms/whatsNew_Layout.aspx?page=PageNo4368&flag=1